Q-omics provides the consensus-scored RNU6ATAC33P profile across patient tissues and cancer cell-line models. RNU6ATAC33P expression is associated with patient survival in 9 of 34 cancer types, with the highest sampling consensus in BLCA. Additionally, RNU6ATAC33P RNA expression shows 10,732 significant gene co-expression associations, with the highest sampling consensus in TGCT. Together, these results highlight BLCA, and TGCT as cancer lineages where RNU6ATAC33P shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.